Pete O’Heeron - CEO, FibroBiologics - Developing & Commercializing Fibroblast Cell-Based Therapies

Pete O’Heeron, MSHA, is the CEO of FibroBiologics ( https://fibrobiologics.com/ ), a biopharmaceutical company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases.Show more

Mr. O’Heeron has over 25 years of medical technology and biotech development experience and brings together the resources necessary to commercialize unique technologies with expertise from business start-ups and biologics, to medical devices and patient centered healthcare delivery.

Prior to founding FibroBiologics, Mr. O’Heeron founded an operational investment group, Advanced Medical Technologies, LLC, that identified early-stage opportunities in the medical field with strong intellectual property potential. He also founded NeoSurg Technologies that developed the T2000 Minimally Invasive Access System. The sale of NeoSurg Technologies to Cooper Surgical occurred in 2006.

Mr. O’Heeron brings decades of executive-level experience at Christus Health Care Corporation and strategic advisory to healthcare companies in the areas of biologics, advanced surgical instrumentation, and telemedicine to the company along with an academic foundation rooted in healthcare administration. He received his Bachelor’s Degree in Healthcare Administration at Texas State University, his Masters in Healthcare Administration from the University of Houston Clear Lake, and his Executive Management Certification in Mergers and Acquisition from University of Chicago.